98
Views
3
CrossRef citations to date
0
Altmetric
Review

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

, &
Pages 143-156 | Published online: 01 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Domenico Ciliberto, Nicoletta Staropoli, Francesca Caglioti, Simona Gualtieri, Lucia Fiorillo, Silvia Chiellino, Antonina Maria De Angelis, Francesco Mendicino, Cirino Botta, Michele Caraglia, Pierfrancesco Tassone & Pierosandro Tagliaferri. (2015) A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?. Cancer Biology & Therapy 16:8, pages 1148-1159.
Read now
Hongqing Zhuang, Zhiyong Yuan, Jun Wang, Qingsong Pang, Lujun Zhao & Ping Wang. (2014) Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy. OncoTargets and Therapy 7, pages 807-813.
Read now
Eftimia Boutsikou, Theodoros Kontakiotis, Paul Zarogoulidis, Kaid Darwiche, Ellada Eleptheriadou, Konstantinos Porpodis, Grammati Galaktidou, Leonidas Sakkas, Wolfgang Hohenforst-Schmidt, Kosmas Tsakiridis, Theodoros Karaiskos & Konstantinos Zarogoulidis. (2013) Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer. OncoTargets and Therapy 6, pages 125-134.
Read now